AbbVie Inc (ABBV)
163.79
+2.98
(+1.85%)
USD |
NYSE |
May 03, 16:00
163.50
-0.29
(-0.18%)
Pre-Market: 20:00
AbbVie Price: 163.79 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 161.16 | 164.25 | 160.74 | 163.79 | 5.497M |
| May 02, 2024 | 162.17 | 162.44 | 158.12 | 160.81 | 5.904M |
| May 01, 2024 | 162.09 | 163.69 | 161.14 | 161.72 | 5.179M |
| Apr 30, 2024 | 161.27 | 163.05 | 159.69 | 162.64 | 5.485M |
| Apr 29, 2024 | 159.59 | 161.55 | 158.56 | 161.52 | 6.226M |
| Apr 26, 2024 | 167.09 | 167.46 | 157.65 | 159.62 | 10.72M |
| Apr 25, 2024 | 167.66 | 169.29 | 165.57 | 167.29 | 5.504M |
| Apr 24, 2024 | 168.52 | 169.11 | 166.74 | 167.80 | 4.075M |
| Apr 23, 2024 | 168.59 | 170.36 | 168.22 | 169.54 | 4.084M |
| Apr 22, 2024 | 167.68 | 169.59 | 166.92 | 167.89 | 5.581M |
| Apr 19, 2024 | 165.02 | 166.60 | 163.25 | 166.41 | 5.532M |
| Apr 18, 2024 | 164.96 | 167.44 | 164.43 | 164.66 | 4.480M |
| Apr 17, 2024 | 164.15 | 164.74 | 163.23 | 164.25 | 4.792M |
| Apr 16, 2024 | 162.18 | 163.74 | 162.08 | 162.54 | 4.882M |
| Apr 15, 2024 | 164.52 | 164.70 | 161.50 | 161.67 | 5.434M |
| Apr 12, 2024 | 164.45 | 164.45 | 160.00 | 162.28 | 7.029M |
| Apr 11, 2024 | 169.20 | 169.37 | 167.23 | 167.52 | 3.307M |
| Apr 10, 2024 | 168.59 | 169.96 | 167.36 | 169.03 | 3.232M |
| Apr 09, 2024 | 169.73 | 170.54 | 167.40 | 170.14 | 5.934M |
| Apr 08, 2024 | 169.21 | 171.97 | 168.40 | 169.80 | 4.745M |
| Apr 05, 2024 | 168.00 | 171.04 | 167.29 | 170.00 | 7.030M |
| Apr 04, 2024 | 177.65 | 177.70 | 167.45 | 167.90 | 10.54M |
| Apr 03, 2024 | 180.72 | 181.60 | 176.60 | 177.33 | 5.893M |
| Apr 02, 2024 | 179.39 | 181.03 | 178.51 | 180.69 | 4.524M |
| Apr 01, 2024 | 181.88 | 181.90 | 179.24 | 180.76 | 3.502M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
62.98
Minimum
Aug 15 2019
182.10
Maximum
Mar 28 2024
121.71
Average
117.50
Median
Jul 16 2021
Price Benchmarks
| Amgen Inc | 311.29 |
| Johnson & Johnson | 149.27 |
| Eli Lilly and Co | 734.97 |
| Merck & Co Inc | 127.51 |
| Pfizer Inc | 27.81 |
Price Related Metrics
| PE Ratio | 48.60 |
| PS Ratio | 5.337 |
| Price to Book Value | 36.12 |
| Price to Free Cash Flow | 13.26 |
| Earnings Yield | 2.06% |
| Market Cap | 289.23B |
| Operating PE Ratio | 21.38 |
| Normalized PE Ratio | 43.59 |